Literature DB >> 6298091

Marathon run: effects on plasma renin activity, renin substrate, angiotensin converting enzyme, and cortisol.

F Fyhrquist, A Dessypris, I Immonen.   

Abstract

Altogether 33 Finnish amateur runners were studied before and after a non-competitive Marathon run over the classical itinerary in Athens in 1976 (n = 8), 1977 (n = 14) and 1978 (n = 11). Plasma renin activity (PRA) rose 3-fold in all runs, whereas plasma renin substrate (RS) concentration did not change significantly. Serum angiotensin converting enzyme (ACE) activity was not changed. Serum cortisol concentration was increased 2-3 fold. The unchanged plasma RS concentration, in spite of increasing PRA, indicates that plasma RS is kept within normal limits during prolonged strenuous physical exercise. One contributing mechanism may be stimulation of RS biosynthesis by cortisol. Low PRA levels in two old runners, 65 and 83 years old, may indicate a decreased ability to respond with renin release to the stimuli of physical exercise.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6298091     DOI: 10.1055/s-2007-1018639

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  3 in total

1.  The serum angiotensin-converting enzyme and angiotensin II response to altered posture and acute exercise, and the influence of ACE genotype.

Authors:  David Woods; Julie Sanders; Alun Jones; Emma Hawe; Peter Gohlke; Steve E Humphries; John Payne; Hugh Montgomery
Journal:  Eur J Appl Physiol       Date:  2003-11-01       Impact factor: 3.078

2.  The response of runners to arduous triathlon competition.

Authors:  G Rogers; C Goodman; D Mitchell; J Hattingh
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1986

3.  The acute effects of exercise and glucose ingestion on circulating angiotensin-converting enzyme in humans.

Authors:  S H Day; C Williams; J P Folland; P Gohlke; A G Williams
Journal:  Eur J Appl Physiol       Date:  2004-08       Impact factor: 3.078

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.